Adani and Sirius form JV to digitally transform India's digital economy
Sirius JV will be owned 51% by Sirius and 49% by Adani
Sirius JV will be owned 51% by Sirius and 49% by Adani
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
His resignation would be effective from March 18, 2024
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
His most recent stint was with Danone India as its Managing Director
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Receives registration of Valganciclovir powder for oral solution in Germany
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
Subscribe To Our Newsletter & Stay Updated